Alex Gorsky now has it all. The CEO of Johnson & Johnson today was named chairman of the drug and consumer products company, replacing Bill Weldon, who is retiring from J&J after four decades.
J&J CEO William Weldon (pictured) got a pay boost last year, despite the company's ongoing problems with recalls, lawsuits and manufacturing problems.
In what appears to be the ultimate step to address its manufacturing and quality control issues, Johnson & Johnson ( $JNJ ) has announced the retirement William Weldon ( photo ) as CEO. For now, he...
Johnson & Johnson ( $JNJ ) CEO Bill Weldon ( photo ) is the highest-paid Big Pharma chief, no question. His $28.7 million in 2010 pay put him far above the second-place executive, and he made even
Johnson & Johnson ( $JNJ ) CEO Bill Weldon ( photo ) is among the corporate executives set to meet with President Obama Friday afternoon to talk about economic woes and prospects for job creation,
Critics of Johnson & Johnson's executive compensation plans lost out at the company's shareholder meeting yesterday. Despite the urgings of unhappy investors who believe CEO William Weldon (
Johnson & Johnson is fighting back against investors who suggest CEO William Weldon ( photo ) is overpaid. Facing critics who are lobbying for a vote against Weldon's pay package, the company
A public employees union has pharma CEO pay in its sights. After lobbying for shareholders' rights to have a "say on pay" at public companies, the American Federation of State, County and Municipal
Now that he's no longer in the driver's seat of the McNeil-comeback bus, back-to-business pronouncements by CEO Bill Weldon ( photo ) have a somewhat more relaxed tone. He "doesn't know" when the Fort
Johnson & Johnson CEO William Weldon ( photo ) tells Bloomberg he "has no plans" to retire. Well, if you'd just collected almost $29 million in compensation and won heaps of praise from your board